{'fraction_non_alphanumeric': 0.03674540682414698, 'fraction_numerical': 0.0026246719160104987, 'mean_word_length': 5.055555555555555, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 1, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[The use of Gn-RH analogues in the management of the endometriosis].

The treatment of endometriosis with the Gn-RH agonists (Gn-RH(a)), is at present the most common medical therapy against this disease. It is used in patients consulting for infertility or pain; alone, associated with surgery or before Assisted Reproduction programs; besides in other special pathologies as Adenomiosis or Extrapelvic endometriosis. The results are very succesfuly, decreasing the extension of the endometriotic lesions in almost all cases; improving the pain in > 90% of patients; and with a good fertility recuperation. It is concluded, that the use of Gn-RH(a) is very useful in the management of the EM, alone or associated to surgery or Assisted Reproductive thechniques.